232 related articles for article (PubMed ID: 34585589)
1. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
2. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
[TBL] [Abstract][Full Text] [Related]
3. The ETS1-LINC00278 negative feedback loop plays a role in COL4A1/COL4A2 regulation in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Wang JT; Yu MM; Wang BS
Neoplasma; 2022 Jul; 69(4):841-858. PubMed ID: 35532293
[TBL] [Abstract][Full Text] [Related]
4. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers with a tumor stage-dependent expression and exploration of the mechanism involved in laryngeal squamous cell carcinoma.
Hui L; Yang N; Yang H; Guo X; Jang X
Oncol Rep; 2015 Nov; 34(5):2627-35. PubMed ID: 26323359
[TBL] [Abstract][Full Text] [Related]
6. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
7. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
[TBL] [Abstract][Full Text] [Related]
8. Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis.
Chen W; Liao L; Lai H; Yi X; Wang D
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1397-1408. PubMed ID: 32067095
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.
Tang XZ; Zhou XG; Zhang XG; Li GS; Chen G; Dang YW; Huang ZG; Li MX; Liang Y; Yao YX; Chen XY; Rong MH; Huang SN
Cancer Biomark; 2020; 29(1):111-124. PubMed ID: 32623386
[TBL] [Abstract][Full Text] [Related]
11. Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma.
Fang W; Shen J
Am J Otolaryngol; 2020; 41(3):102391. PubMed ID: 31932027
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
13. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
14. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
15. Identification of Significant Secreted or Membrane-Located Proteins in Laryngeal Squamous Cell Carcinoma.
Yan L; Hu C; Ji Y; Zou L; Zhao Y; Zhu Y; Wang X
J Immunol Res; 2022; 2022():9089397. PubMed ID: 35655921
[TBL] [Abstract][Full Text] [Related]
16. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of laryngeal squamous cell carcinoma: seeking key candidate genes and pathways.
Ma J; Hu X; Dai B; Wang Q; Wang H
PeerJ; 2021; 9():e11259. PubMed ID: 33954053
[TBL] [Abstract][Full Text] [Related]
18. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
19. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.
Yang ML; Zhang JH; Li S; Zhu R; Wang L
Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533
[TBL] [Abstract][Full Text] [Related]
20. A preliminary analysis of prognostic genes in advanced laryngeal squamous cell carcinoma patients with postoperative radiotherapy.
Hu C; Lao Z; Yan L; Song X; Wang J
Pathol Res Pract; 2023 Jan; 241():154229. PubMed ID: 36509010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]